Acorda Therapeutics Total Liabilities

Acorda Therapeutics (ACOR) currently reports a total liabilities of $270M as of March 2024. That compares with $300M in the prior-year period — down 10.3% year over year. Use the charts on this page to explore Acorda Therapeutics's total liabilities history and peer comparisons.

Acorda Therapeutics's total liabilities decreased from $300M to $270M — a 10.3% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acorda Therapeutics reported $270M in total liabilities as of March 2024. That compares with $300M in the prior-year period — down 10.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $270M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acorda Therapeutics, and consider following ACOR for alerts when major investors trade the stock.

Acorda Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $270M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACOR with unrelated industries.